Clinical cardiology 2014

214.        Mearns, B.M., Interventional cardiology: Does preventive PCI reduce the risk of adverse events in patients with acute STEMI? Nat Rev Cardiol, 2013. 10(11): p. 613.

215.        Mearns, B.M., Interventional cardiology: Platelet reactivity after stenting. Nat Rev Cardiol, 2013. 10(10): p. 551.

216.        Mearns, B.M., Interventional cardiology: biodegradable-polymer DES versus second-generation durable-polymer DES. Nat Rev Cardiol, 2014. 11(1): p. 6.

217.        Meier, P. and A. Timmis, Almanac 2012: Interventional Cardiology. The National Society Journals present selected research that has driven recent advances in clinical cardiology. Hellenic J Cardiol, 2013. 54(4): p. 242-54.

218.        Meier, P. and A. Timmis, Almanac 2012: interventional cardiology. Rev Port Cardiol, 2013. 32(5): p. 447-57.

219.        Menahem, S., D. Fink, and F.B. Mimouni, Trends in paediatric, neonatal, and adult cardiology publications over the past 10 years. Cardiol Young, 2013: p. 1-6.

220.        Mezzani, A. and P. Giannuzzi, The Italian cardiological guidelines for eligibility in competitive sports: food for thought in preventive cardiology. J Cardiovasc Med (Hagerstown), 2013. 14(7): p. 518-9.

221.        Milfred-Laforest, S.K., et al., Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. J Card Fail, 2013. 19(5): p. 354-69.

222.        Milfred-LaForest, S.K., et al., Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. Pharmacotherapy, 2013. 33(5): p. 529-48.

223.        Miltner, B., et al., [European Society of Cardiology guidelines for the management of grown-up congenital heart disease]. Rev Med Liege, 2013. 68(9): p. 450-7.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28